COVID-19 Impact on Getinge AB’s Revenue and Operations (Medical Devices)

COVID-19 Impact on Getinge AB’s Revenue and Operations (Medical Devices)

  • May 2020 •
  • 11 pages •
  • Report ID: 5930842 •
  • Format: PDF
COVID-19 Impact on Getinge AB’s Revenue and Operations (Medical Devices)

Summary
Getinge AB (Getinge) is a medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care, headquartered in Sweden with global manufacturing and sales reach.Getinge’s product range include surgical tables, lights, ventilators and anaesthesia equipment, heart-lung machines with accompanying disposables, equipment and instruments for cardiac surgery, vascular surgery devices, cardiac assist devices, patient lifting devices, hospital beds, stretchers and couches, mattresses for treating and preventing pressure sores, disinfectors, sterilization equipment, and documentation systems and accessories.

The report, COVID-19 Impact on Getinge AB’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Getinge AB is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Getinge AB is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights
- Order intake for Q1 2020 increased by 47.2% organically compared to Q1 2019.
- Since the outbreak of the COVID-19 pandemic, Getinge has seen an increased global demand for advanced ventilators, extra corporeal life support (ECLS) equipment, and advanced monitoring for intensive care units.
- Inspite of the heavy impact in Europe and rapid rise of COVID-19 cases in the US, the general outlook for sales has a significantly positive outlook.
- Getinge reported a sharp organic order growth for Q1 to two product segments of critical care and cardiopulmonary in the acute care therapies business, which offer products for treating patients diagnosed with COVID-19.
- The order intake for life science and surgical workflows declined as a result of lower activity in the relevant areas of hospitals and life sciences.

Scope
The report provides a comprehensive analysis of the impact of COVID-19 on Getinge AB -
- It provides insights on Getinge AB’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy
- An overview of how Getinge AB will be affected by the COVID-19 pandemic.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.